Suzette Delaloge

Suzette Delaloge

UNVERIFIED PROFILE

Are you Suzette Delaloge?   Register this Author

Register author
Suzette Delaloge

Suzette Delaloge

Publications by authors named "Suzette Delaloge"

Are you Suzette Delaloge?   Register this Author

100Publications

4265Reads

40Profile Views

A new automated method to evaluate 2D mammographic breast density according to BI-RADS® Atlas Fifth Edition recommendations.

Eur Radiol 2019 Jul 15;29(7):3830-3838. Epub 2019 Feb 15.

Imaging Department, Gustave Roussy, 114 rue Edouard Vaillant, 94800, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06016-yDOI Listing
July 2019

Modifiable risk factors for advanced vs. early breast cancer in the French E3N cohort.

Int J Cancer 2019 Apr 19. Epub 2019 Apr 19.

Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32354DOI Listing
April 2019

[Subcutaneous administration of trastuzumab at home: Feedback of patients treated in 2016 by Santé service].

Bull Cancer 2018 Dec 19;105(12):1126-1134. Epub 2018 Nov 19.

Institut Gustave-Roussy, service oncologie, 114, rue Edouard-Vaillant, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.10.005DOI Listing
December 2018

All simulation models of breast cancer are wrong but some are useful.

Lancet Glob Health 2018 08;6(8):e818-e819

Department of Cancer Medicine, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S2214109X183027
Publisher Site
http://dx.doi.org/10.1016/S2214-109X(18)30273-0DOI Listing
August 2018

Patient satisfaction with a rapid diagnosis of suspicious breast lesions: Association with distress and anxiety.

Breast J 2018 03 13;24(2):154-160. Epub 2017 Jul 13.

Department of Medical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12856DOI Listing
March 2018

Breast tissue density change after oophorectomy in BRCA mutation carrier patients using visual and volumetric analysis.

Br J Radiol 2018 Feb 5;91(1083):20170163. Epub 2018 Jan 5.

2 Department of Radiology, Gustave Roussy , Gustave Roussy , Villejuif , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20170163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965464PMC
February 2018

Value of whole breast magnetic resonance elastography added to MRI for lesion characterization.

NMR Biomed 2018 Jan 26;31(1). Epub 2017 Oct 26.

Paris Diderot University, Sorbonne Paris Cité, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nbm.3795DOI Listing
January 2018

Steroid hormone profiling in human breast adipose tissue using semi-automated purification and highly sensitive determination of estrogens by GC-APCI-MS/MS.

Anal Bioanal Chem 2018 Jan 16;410(1):259-275. Epub 2017 Nov 16.

Laboratoire d'Etude des Résidus et Contaminants dans les Aliments (LABERCA), ONIRIS, LUNAM Université, 44307, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00216-017-0717-8DOI Listing
January 2018

Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?

Eur J Cancer 2017 11 4;85:23-30. Epub 2017 Sep 4.

Department of Radiology, Gustave Roussy, Villejuif, France; Paris-Sud University, IR4M UMR 8081, 91405 Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.002DOI Listing
November 2017

Targeting PI3K/AKT pathway in triple-negative breast cancer.

Lancet Oncol 2017 10 8;18(10):1293-1294. Epub 2017 Aug 8.

Department of Medical Oncology, Gustave Roussy, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045173051
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(17)30514-4DOI Listing
October 2017

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

N Engl J Med 2017 08 4;377(6):523-533. Epub 2017 Jun 4.

From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdańsk, Gdańsk, Poland (E.S.); National Cancer Center-Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (B.X.), and the First Hospital of Jilin University, Changchun (W.L.) - both in China; Basser Center, University of Pennsylvania, Philadelphia (S.M.D.); National Hospital Organization, Osaka National Hospital, Osaka, Japan (N.M.); Institut Gustave Roussy, Villejuif, France (S.D.); Beth Israel Deaconess Medical Center, Dana-Farber Harvard Cancer Center, Boston (N.T.); Christie Hospital NHS Foundation Trust and Faculty of Biology, Medicine and Health, University of Manchester, Manchester (A.A.), and AstraZeneca, Macclesfield (S.R.) - both in the United Kingdom; AstraZeneca, Gaithersburg, MD (W.W., C.G.); and University of Padua and Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1706450DOI Listing
August 2017

Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort.

Cancer Epidemiol 2017 08 8;49:156-160. Epub 2017 Jul 8.

CESP Inserm, Villejuif, France; Department of Clinical and Experimental Medicine, University of Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2017.07.003DOI Listing
August 2017

Tumor-specific circulating angiogenic progenitors in breast and renal cell cancer: What prospects?

Eur J Cancer 2017 05 8;77:153-154. Epub 2017 Apr 8.

Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Inserm U931, Cancer Biomarkers, Université Paris Saclay, Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.03.016DOI Listing
May 2017

Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients.

Mol Oncol 2016 11 5;10(9):1430-1436. Epub 2016 Aug 5.

Departement de Biologie et Pathologie Médicales, Gustave Roussy Cancer Campus, Villejuif, France; Laboratoire de Recherche Translationnelle et Centre de Ressources Biologiques, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423214PMC
November 2016

Extended anti-HER2 therapy in early breast cancer: longer beats shorter?

Curr Opin Oncol 2016 11;28(6):469-475

Departments of Cancer Medicine and Breast Oncology, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000325DOI Listing
November 2016

Uncovering Professional Attitudes Toward Treatment of Rare Carcinomas of the Breast: An International Practice e-Survey Involving 32 Countries.

Breast J 2016 Jan-Feb;22(1):96-100. Epub 2015 Oct 28.

Department of Medical Oncology, Breast Cancer Unit, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12525DOI Listing
October 2016

Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.

Breast J 2016 Sep 27;22(5):520-8. Epub 2016 Jun 27.

Radiology Department, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12627DOI Listing
September 2016

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

N Engl J Med 2016 Aug;375(8):717-29

From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602253DOI Listing
August 2016

The ratio of CD8/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma .

Oncoimmunology 2016 18;5(10):e1218106. Epub 2016 Aug 18.

Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1218106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087306PMC
August 2016

[Not Available].

Authors:
Suzette Delaloge

Bull Cancer 2016 Jun;103(6 Suppl 1):S90-1

Comité de pathologie mammaire, Gustave Roussy - Cancer Campus, 114, rue Edouard Vaillant, 94800 Villejuif, France.. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(16)30150-3DOI Listing
June 2016

Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.

Int J Cancer 2016 May 4;138(10):2415-27. Epub 2016 Feb 4.

Inserm (Institut National De La Santé Et De La Recherche Médical), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, Villejuif, F-94805, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29987DOI Listing
May 2016

The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?

Am Soc Clin Oncol Educ Book 2014 :e5-10

From the Department of Medical Oncology and INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France; Department of Medical Oncology, Centre Paoli-Calmettes, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e5DOI Listing
December 2015

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Science 2015 Nov 29;350(6263):972-8. Epub 2015 Oct 29.

Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, 17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aad0779DOI Listing
November 2015

Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials.

J Clin Oncol 2015 Aug 22;33(24):2600-8. Epub 2015 Jun 22.

Ciara C. O'Sullivan and Jo Anne Zujewski, National Cancer Institute, Bethesda, MD; Ian Bradbury, Christine Campbell, and Eileen Holmes, Frontier Science, Inverness-shire, Scotland; Marc Spielmann and Suzette Delaloge, Institut de Cancérologie Gustave Roussy, Villejuif, France; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland; Joseph P. Costantino and Priya Rastogi, University of Pittsburgh, Pittsburgh, PA; Dimitrios Zardavas, Breast International Group; Karla V. Ballman, Mayo Clinic, Rochester, MN; Evandro de Azambuja and Martine Piccart-Gebhart, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium; and Richard D. Gelber, Harvard Medical School, Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534523PMC
http://dx.doi.org/10.1200/JCO.2015.60.8620DOI Listing
August 2015

Effect of PALB2 status on breast cancer precision medicine.

Lancet Oncol 2015 Jun 7;16(6):598-600. Epub 2015 May 7.

INSERM UMR 981, Gustave Roussy Institute, Villejuif, France; Laboratory of Genetic Stability and Tumorigenesis UMR 8200; Gustave Roussy Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70182-8DOI Listing
June 2015

[Molecular signatures of breast cancer: What clinical utility?].

Bull Cancer 2015 Jun;102(6 Suppl 1):S102-5

Department of medical oncology, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U981, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(15)31227-3DOI Listing
June 2015

Ki67--no evidence for its use in node-positive breast cancer.

Nat Rev Clin Oncol 2015 May 17;12(5):296-301. Epub 2015 Mar 17.

Department of Medical Oncology, Gustave Roussy Institute, 114 rue E. Vaillant, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.46DOI Listing
May 2015

Reply to V.P. Retèl et al, D. Gauchan et al, and C. Rahilly-Tierney et al.

J Clin Oncol 2015 May 6;33(14):1629-30. Epub 2015 Apr 6.

Institute Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.5568DOI Listing
May 2015

[Trends and evolutions of French breast cancer research: a bibliometric study].

Bull Cancer 2015 May 14;102(5):417-27. Epub 2015 Apr 14.

Institut Gustave-Roussy, comité de pathologie mammaire, 114, rue Édouard-Vaillant, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.02.017DOI Listing
May 2015

A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort.

Breast Cancer Res Treat 2015 Apr 6;150(2):415-26. Epub 2015 Mar 6.

Inserm (Institut National de la Santé et de la Recherche Médicale), Centre for Research in Epidemiology and Population Health (CESP), U1018, Team 9, 114 rue Édouard Vaillant, 94805, Villejuif Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3321-7DOI Listing
April 2015

Cost effectiveness of molecular profiling for adjuvant decision making in patients with node-negative breast cancer.

J Clin Oncol 2014 Nov 6;32(31):3513-9. Epub 2014 Oct 6.

All authors: Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.9931DOI Listing
November 2014

[Psychological adjustment in couples facing woman's breast cancer: perceptions of spousal support].

Bull Cancer 2014 Jul-Aug;101(7-8):690-7

Université Paris-Descartes, Institut de psychologie, 71, avenue Édouard-Vaillant, 92100 Boulogne-Billancourt, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1951DOI Listing
September 2014

Exploring frontiers: use of complementary and alternative medicine among patients with early-stage breast cancer.

Breast 2014 Jun 13;23(3):279-85. Epub 2014 Feb 13.

Institut Gustave Roussy, Department of Medical Oncology, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2014.01.009DOI Listing
June 2014

Chk1 as a new therapeutic target in triple-negative breast cancer.

Breast 2014 Jun 15;23(3):250-8. Epub 2014 Mar 15.

Institut National de la Santé et de la Recherche Médicale (INSERM) UMR981, Villejuif F-94800, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2014.02.004DOI Listing
June 2014

Added value of Virtual Touch IQ shear wave elastography in the ultrasound assessment of breast lesions.

Eur J Radiol 2014 May 6;83(5):773-7. Epub 2014 Feb 6.

Radiology Department, Gustave Roussy, Villejuif, France; UMR 8081, IR4M, Paris-Sud University, 91405 Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2014.01.021DOI Listing
May 2014

Cost-effectiveness of a genetic test for breast cancer risk--letter.

Cancer Prev Res (Phila) 2014 Apr 5;7(4):475. Epub 2014 Feb 5.

28 rue Laënnec, 69373 Lyon 8, France. Phone: 33-4-78-78-59-12; Fax: 33-4-78-78-27-20; and Suzette Delaloge, Institut Gustave Roussy, 114 rue Edouard-Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-13-0429DOI Listing
April 2014

Changes in psychological adjustment over the course of treatment for breast cancer: the predictive role of social sharing and social support.

Psychooncology 2014 Mar 10;23(3):291-8. Epub 2013 Oct 10.

Institut de Psychologie, Université Paris Descartes, Paris, France; Unité de Psycho-Oncologie, Institut de Cancérologie Gustave Roussy, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3420DOI Listing
March 2014

The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy.

Breast 2013 Dec 19;22(6):1189-93. Epub 2013 Sep 19.

Department of Breast and Plastic Surgery, Institut Gustave Roussy, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.055DOI Listing
December 2013

Outcome of full-thickness chest wall resection for isolated breast cancer recurrence.

Eur J Cardiothorac Surg 2013 Oct 3;44(4):637-42. Epub 2013 Mar 3.

Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Hôpital Marie-Lannelongue, Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezt105DOI Listing
October 2013

Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers.

Clin Breast Cancer 2013 Oct 3;13(5):401-8. Epub 2013 Jul 3.

INSERM U981 "Identification of molecular predictors and new targets for cancer treatment", Gustave Roussy Cancer Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2013.02.001DOI Listing
October 2013

A model to predict the risk of upgrade to malignancy at surgery in atypical breast lesions discovered on percutaneous biopsy specimens.

Ann Surg Oncol 2013 Sep 24;20(9):2850-7. Epub 2013 May 24.

Department of Surgery, Institut Gustave Roussy and University Paris Sud, Villejuif Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-013-2989-3DOI Listing
September 2013

Quantification of residual risk of relapse in breast cancer patients optimally treated.

Breast 2013 Aug;22 Suppl 2:S92-5

INSERM Unit U981 and Breast Cancer Unit, Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.07.017DOI Listing
August 2013

Outcome in breast molecular subtypes according to nodal status and surgical procedures.

Am J Surg 2013 Jun 9;205(6):662-7. Epub 2013 Jan 9.

Department of Breast Surgery, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2012.06.006DOI Listing
June 2013

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.

Int J Breast Cancer 2013 9;2013:130470. Epub 2013 May 9.

Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France ; Laboratory of Circulating Cancer Biomarker, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/ijbc/2013/130470/
Publisher Site
http://dx.doi.org/10.1155/2013/130470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665249PMC
June 2013

Targeted therapy-induced radiation recall.

Eur J Cancer 2013 May 8;49(7):1662-8. Epub 2013 Jan 8.

Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.12.009DOI Listing
May 2013

Landscape and evolution of therapeutic research for breast cancer patients.

Breast Cancer Res Treat 2013 Feb 14;138(1):319-24. Epub 2013 Feb 14.

INSERM Unit U981 and Université Paris Sud, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2436-yDOI Listing
February 2013

Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing.

Hum Pathol 2012 Nov 14;43(11):1932-9. Epub 2012 May 14.

Department of Medicine, Institut Gustave Roussy, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2012.02.002DOI Listing
November 2012

Triple-negative breast cancer: are we making headway at least?

Ther Adv Med Oncol 2012 Jul;4(4):195-210

Breast Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834012444711DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384094PMC
July 2012